Neurocrine Biosciences, Inc. (NBIX)

130.87 +2.49 (+1.94%) USD  |  NASDAQ  |  Feb 24, 16:00
130.96 +0.09 (+0.07%) After-Hours: 19:30
More

Neurocrine Biosciences Preferred Stock (Quarterly)

Preferred Stock (Quarterly) Chart

View Preferred Stock (Quarterly) for NBIX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Preferred Stock (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Preferred Stock (Quarterly) Range, Past 5 Years

View Preferred Stock (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Preferred Stock (Quarterly) Benchmarks

View Preferred Stock (Quarterly) Benchmarks
Start Trial
Glaukos Corp. Upgrade
Edgewise Therapeutics, Inc. Upgrade
Nuvalent, Inc. Upgrade
Marker Therapeutics, Inc. Upgrade
CapsoVision, Inc. Upgrade